KPRX Q1 2026 Earnings BetterthanExpected Loss Amid Continued Pipeline Development UiPath Q1 2026 Earnings Earnings Beat Driven by Cost Discipline Stock Rises PRTS Q1 2026 Earnings EPS Surprises to the Upside Revenue Details Not Disclosed Design Therapeutics Inc DSGN Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid Quiet Quarter PRME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines